Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.6400
-0.0105-1.61%
At close: Jun 18, 5:00 PM EST
$0.6500
0.011.56%
After Hours: Jun 18, 7:57 AM EST
Rockwell Medical Inc Analyst Ratings
RMTINASDAQ
Rockwell Medical Analyst Ratings and Price Targets | NASDAQ:RMTI | Benzinga
Rockwell Medical Inc has a consensus price target of $4 based on the ratings of 3 analysts. The high is $5 issued by Rodman & Renshaw on November 14, 2024. The low is $2 issued by HC Wainwright & Co. on March 30, 2026. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 30, 2026, January 26, 2026, and November 13, 2025, respectively. With an average price target of $2.33 between HC Wainwright & Co., there's an implied 258.97% upside for Rockwell Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Rodman & Renshaw
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Rockwell Medical
Loading calendar...
FAQ
What is the target price for Rockwell Medical (RMTI) stock?
The latest price target for Rockwell Medical (NASDAQ:RMTI) was reported by HC Wainwright & Co. on March 30, 2026. The analyst firm set a price target for $2.00 expecting RMTI to rise to within 12 months (a possible 207.69% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Rockwell Medical (RMTI)?
The latest analyst rating for Rockwell Medical (NASDAQ:RMTI) was provided by HC Wainwright & Co., and Rockwell Medical maintained their buy rating.
When was the last upgrade for Rockwell Medical (RMTI)?
There is no last upgrade for Rockwell Medical
When was the last downgrade for Rockwell Medical (RMTI)?
There is no last downgrade for Rockwell Medical.
When is the next analyst rating going to be posted or updated for Rockwell Medical (RMTI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rockwell Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rockwell Medical was filed on March 30, 2026 so you should expect the next rating to be made available sometime around March 30, 2027.
Is the Analyst Rating Rockwell Medical (RMTI) correct?
While ratings are subjective and will change, the latest Rockwell Medical (RMTI) rating was a maintained with a price target of $2.50 to $2.00. The current price Rockwell Medical (RMTI) is trading at is $0.65, which is out of the analyst’s predicted range.
